相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Thymoma and thymic carcinomas
Marta Scorsetti et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Thymic carcinoma outcomes and prognosis: Results of an international analysis
Usman Ahmad et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2015)
The Impact of Thymoma Histotype on Prognosis in a Worldwide Database
Cleo-Aron Weis et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Neoadjuvant chemoradiotherapy for locally advanced thymic tumors: A phase II, multi-institutional clinical trial
Robert J. Korst et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2014)
A Practical Guide from the International Thymic Malignancy Interest Group (ITMIG) Regarding the Radiographic Assessment of Treatment Response of Thymic Epithelial Tumors Using Modified RECIST Criteria
Marcelo F. Benveniste et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
Martyn E. Caplin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
High prevalence of infections and autoimmunity in patients with thymoma
Andreas Holbro et al.
HUMAN IMMUNOLOGY (2012)
Thymoma-A Clinico-Pathological Long-Term Study with Emphasis on Histology and Adjuvant Radiotherapy Dose
Thomas Harnath et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Meta-Analysis on the Effects of Octreotide on Tumor Mass in Acromegaly
Andrea Giustina et al.
PLOS ONE (2012)
Thymic Malignancies: From Clinical Management to Targeted Therapies
Ronan J. Kelly et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The Masaoka-Koga Stage Classification for Thymic Malignancies Clarification and Definition of Terms
Frank C. Detterbeck et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Management of Stage I and II Thymoma
Frank C. Detterbeck et al.
THORACIC SURGERY CLINICS (2011)
Thymoma and Thymic Carcinoma Molecular Pathology and Targeted Therapy
Philipp Stroebel et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
Anja Rinke et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Complete regression of a thymoma to glucocorticoids, commenced for palliation of symptoms
Shaney Barratt et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2007)
Preoperative steroid pulse therapy for invasive thymoma - Clinical experience and mechanism of action
Y Kobayashi et al.
CANCER (2006)
Thymic tumors
FC Detterbeck et al.
ANNALS OF THORACIC SURGERY (2004)
Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas:: A retrospective analysis
P Ströbel et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Multimodal management of stages III-IVA malignant thymoma
S Bretti et al.
LUNG CANCER (2004)
Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: An Eastern Cooperative Oncology Group phase II trial
PJ Loehrer et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Malignant thymoma in the United States: Demographic patterns in incidence and associations with subsequent malignancies
EA Engels et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Opportunities in somatostatin research: Biological, chemical and therapeutic aspects
G Weckbecker et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
New WHO histologic classification predicts prognosis of thymic epithelial tumors - A clinicopathologic study of 200 thymoma cases from China
G Chen et al.
CANCER (2002)
Somatostatin analogs and prednisone in advanced refractory thymic tumors
G Palmieri et al.
CANCER (2002)
Multimodal treatment of metastatic thymic carcinoma including high-dose chemotherapy with autologous stem cell transplantation - Report of a case with more than 4-year disease-free survival
DB Geffen et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2001)
分享论文
